LMRI
Lumexa Imaging Holdings, Inc.
$12.18
+0.02 (+0.16%)
At close · Jul 9
Market Cap
$1.15B
Shares
96,080,735
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$12.18
Open$12.27
Day$11.45–12.30
52W$6.56–19.45
Avg vol 30d731K
Short int2.8M · 2.9% float · 3.4d
Short vol79%
Last earningsMay 12, 2026
DataDec 2025–Jul 2026
Filing10-Q · May 12
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Buy
Momentum
Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+30%
above
RSI (14)
66
neutral
MACD trend
Positive
52-week position
44%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+43%
trailing
6-month return
−22%
trailing
YTD return
−34%
this year
Relative strength
−31%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
1 of 89 funds reported for Jun 30 · net +50 sh shares · +1 new
Insider flow
Accumulating
Net +$476.9K over 90 days · 0% sells
Short interest
Falling
2.94% of float · ▼ -8.0% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
89 holders — 13F breadth
Squeeze score
58
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
90%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
6.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 12, 2026
Consolidated revenues
· year ending December 31, 2026
Initiated
$1.05B – $1.1B
Adjusted EBITDA
· year ending December 31, 2026
Non-GAAP
Initiated
$234M – $242M
Adjusted EPS
· year ending December 31, 2026
Non-GAAP
Initiated
$0.71 – $0.77
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+30%
Bullish
RSI (14)
66
Neutral
MACD trend
Positive
Bullish
52-week position
44%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Accumulating
1 of 89 funds reported for Jun 30 · net +50 sh shares · +1 new
Insider flow
Accumulating
Net +$476.9K over 90 days · 0% sells
Short interest
Falling
2.94% of float · ▼ -8.0% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
89 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $7
Now $12 · 44%
52-wk high $19
vs 50-day avg +30%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $51.2M | Q1 2026 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 20.3% | Q1 2026 | — |
|
|
|||
| Adjusted EPS non-GAAP | $0.18 | Q1 2026 | — |
| Consolidated same-center advanced volume growth | 5.6% | Q1 2026 | — |
| System-wide same-center advanced volume growth | 5.6% | Q1 2026 | — |
| Same center advanced volume growth (consolidated) | 12.7% | Q4 2025 | — |
| Same center advanced volume growth (system-wide) | 7.1% | FY2025 | — |
| System-wide revenue growth | 8.2% | FY2025 | — |
| De novo centers opened | 3 | Q4 2025 | — |
| Expected Adjusted EBITDA non-GAAP | $229M | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LMRI
this stock
Lumexa Imaging Holdings, Inc.
|
$1.15B | -34.2% | — | — | 2.9% |
|
ABT
Abbott Laboratories
|
$163.42B | -24.3% | +5.7% | 26.3 | 1.3% |
|
SYK
Stryker Corp
|
$126.42B | -6.7% | +11.2% | 38.2 | 1.8% |
|
MDT
Medtronic plc
|
$107.36B | -13.5% | +8.4% | 22.5 | 1.5% |
|
BSX
Boston Scientific Corp
|
$66.54B | -52.8% | +5.5% | 18.7 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LMRI | +5.1% | +42.8% | -21.7% | +8.0% | -34.2% |
| SPY | +0.8% | +2.0% | +8.9% | +0.7% | +10.2% |
| vs SPY | +4.3% | +40.8% | -30.6% | +7.3% | -44.4% |